Continuing Education Course #2: Current Understanding of Hemostasis
Open Access
- 30 November 2010
- journal article
- review article
- Published by SAGE Publications in Toxicologic Pathology
- Vol. 39 (1), 273-280
- https://doi.org/10.1177/0192623310389474
Abstract
The goal of this review is to briefly summarize the two primary pathways of hemostasis, primary hemostasis and secondary hemostasis, as well as to summarize anticoagulant mechanisms and fibrinolysis. In addition, this review will discuss pathologies of hemostasis and the mechanisms of the various drugs that are available to impact these pathways to prevent either thrombosis or bleeding. While many of the main drugs that are used to treat disorders of hemostasis have been used for decades, greater understanding of hemostasis has led to development of various new drugs that have come onto the market recently or are close to coming onto the market. Thus, improved understanding of hemostasis continues to lead to benefits for patients.Keywords
This publication has 84 references indexed in Scilit:
- Factor V Is an Anticoagulant Cofactor for Activated Protein C during Inactivation of Factor VaPathophysiology of Haemostasis and Thrombosis, 2010
- Factor VIII and von Willebrand factor interaction: biological, clinical and therapeutic importanceHaemophilia, 2009
- How I treat von Willebrand diseaseBlood, 2009
- Platelet glycoprotein Ibα forms catch bonds with human WT vWF but not with type 2B von Willebrand disease vWFJCI Insight, 2008
- Serpins in thrombosis, hemostasis and fibrinolysisJournal of Thrombosis and Haemostasis, 2007
- The role of von Willebrand factor in thrombus formationThrombosis Research, 2007
- Integrin structures and conformational signalingCurrent Opinion in Cell Biology, 2006
- Antiplatelet action of R‐99224, an active metabolite of a novel thienopyridine‐type Gi‐linked P2T antagonist, CS‐747British Journal of Pharmacology, 2001
- Low-Molecular-Weight HeparinsNew England Journal of Medicine, 1997
- Inhibition of platelet prostaglandin synthetase by oral aspirin.JCI Insight, 1978